$Precision BioSciences (DTIL.US)$Reuters· just Precision BioSciences Receives U.S. FDA Fast Track Designation for Pbgene-Hbv, a First-in-Class Gene Editing Therapy Designed to Eliminate the Root Cause of Chronic Hepatitis B
$Precision BioSciences (DTIL.US)$ Precision BioSciences Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Update Positive First-ever in vivo gene editing therapy cleared for Hepatitis B treatment globally Successful initial clinical results with PBGENE-HBV showing substantial antiviral activity Partner iECURE achieved complete clinical response in first infant treated for OTC deficiency Strong cash position of $108.5M with runway into H2 2026 Negative Revenu...
$Precision BioSciences (DTIL.US)$ iECURE Announces Presentation of Full Data for the First Infant Dosed with ECUR-506 in OTC-HOPE Phase 1/2 Clinical Trial at the 2025 ACMG Annual Clinical Genetics Meeting Friday, 21st March at 8:00 am First participant dosed achieved complete clinical response per study protocol and data suggests partial restoration of functional OTC enzyme activity in the liver iECURE, Inc., a gene editing company focused on the development of mutation-agnostic in vivo gene ...
NOTE! 1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice. 2. Do NOT open position WITHOUT chart confirmation, indicators, momentum. 3. Scale out and secure profits. 4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability. 5. I DO NOT give buy or sell advice 6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; F...
31
14
2
Report
Mangkawat
:
dr jag. delution of pnbk.us mean possible to decline?
Jaguar8
OPMangkawat
:
The news itself is dilution for existing shareholders BUT take note not all PP plummets. It all comes down to market sentiment. Look at it- it is up.
$Precision BioSciences (DTIL.US)$Precision BioSciences To Present Preclinical Safety And Efficacy Data For PBGENE-HBV At Global Hepatitis Summit 2025 On Mar. 21
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.
Precision BioSciences Stock Forum
Revolutionary Gene Editing Treatment for Hepatitis B Wins FDA Fast Track Status
Precision BioSciences Receives U.S. FDA Fast Track Designation for Pbgene-Hbv, a First-in-Class Gene Editing Therapy Designed to Eliminate the Root Cause of Chronic Hepatitis B
Breakthrough: Precision BioSciences' Gene Editing Therapy Delivers First Results in HBV Patients
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Update
Positive
First-ever in vivo gene editing therapy cleared for Hepatitis B treatment globally
Successful initial clinical results with PBGENE-HBV showing substantial antiviral activity
Partner iECURE achieved complete clinical response in first infant treated for OTC deficiency
Strong cash position of $108.5M with runway into H2 2026
Negative
Revenu...
Breakthrough: First Infant Successfully Treated in iECURE's OTC Deficiency Gene Therapy Trial
iECURE Announces Presentation of Full Data for the First Infant Dosed with ECUR-506 in OTC-HOPE Phase 1/2 Clinical Trial at the 2025 ACMG Annual Clinical Genetics Meeting
Friday, 21st March at 8:00 am
First participant dosed achieved complete clinical response per study protocol and data suggests partial restoration of functional OTC enzyme activity in the liver
iECURE, Inc., a gene editing company focused on the development of mutation-agnostic in vivo gene ...
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; F...
Revolutionary Gene Therapy Achieves 99% Hepatitis B Virus Elimination - Key Trial Updates
Revolutionary DMD Treatment Restores 93% Muscle Strength, Could Help 60% of Patients
No comment yet